Genetic Changes In The Ebola Virus. Part 2 of 2

He is director of the Center for Genome Sciences at the US Army Medical Research Institute of Infectious Diseases in Frederick, MD. Study pattern author and US Army Captain Jeffrey Kugelman, a viral geneticist at the institute, said, “The virus has not only changed since these therapies were designed, but it’s continuing to change”. Three of the mutations found by the researchers appeared during the mainstream West African epidemic.

So “Ebola researchers neediness to assess drug efficacy in a timely manner to make sure that valuable resources are not spent developing therapies that no longer work”. While genetic sequence-based drugs are considered to be the best desire for future treatment of Ebola outbreaks, none has been approved by the US Food and Drug Administration or any other regulator. However, some of the drugs are being tested on some patients, and a clinical trial of one of the drugs is scheduled to begin in Sierra Leone in the coming months surgery. Sierra Leone, along with Guinea and Liberia, are the three West African nations at the epicenter of the on the qui vive outbreak that has led to nearly 21300 infections and more than 8400 deaths.

Parts: 1 2